Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.66 |
| ▸ | LMNA | P02545 | 2/20 | 0.57 |
| ▸ | POLB | P06746 | 1/20 | 0.57 |
| ▸ | NPSR1 | Q6W5P4 | 4/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.56 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.44 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.37 |
| ▸ | GRM2 | Q14416 | 2/20 | 0.35 |
| ▸ | GRM3 | Q14832 | 2/20 | 0.35 |
| ▸ | GRM4 | Q14833 | 2/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Camphoric Acid SCHEMBL12084182 | 1.00 | ALDH1A1 (0.66) | ALDH1A1LMNAPOLBNPSR1L3MBTL1 | |
| Camphoric Acid SCHEMBL2513165 | 1.00 | ALDH1A1 (0.66) | ALDH1A1LMNAPOLBNPSR1L3MBTL1 | |
| Camphoric Acid SCHEMBL30078310 | 1.00 | ALDH1A1 (0.66) | ALDH1A1LMNAPOLBNPSR1L3MBTL1 | |
| Camphoric Acid SCHEMBL23643 | 1.00 | ALDH1A1 (0.66) | ALDH1A1LMNAPOLBNPSR1L3MBTL1 | |
| Camphoric Acid SCHEMBL1738809 | 1.00 | ALDH1A1 (0.66) | ALDH1A1LMNAPOLBNPSR1L3MBTL1 | |
| Camphoric Acid SCHEMBL12308 | 1.00 | ALDH1A1 (0.66) | ALDH1A1LMNAPOLBNPSR1L3MBTL1 | |
| Camphoric Acid SCHEMBL7102028 | 1.00 | ALDH1A1 (0.66) | ALDH1A1LMNAPOLBNPSR1L3MBTL1 | |
| Camphoric Acid SCHEMBL12083956 | 1.00 | ALDH1A1 (0.66) | ALDH1A1LMNAPOLBNPSR1L3MBTL1 | |
| Camphoric Acid SCHEMBL7099871 | 1.00 | ALDH1A1 (0.66) | ALDH1A1LMNAPOLBNPSR1L3MBTL1 | |
| Camphoric Acid SCHEMBL27486599 | 1.00 | ALDH1A1 (0.66) | ALDH1A1LMNAPOLBNPSR1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 555 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12630520-B2 | Left-handed bicyclic morpholine and salt thereof, preparation method therefor, pharmaceutical composition, and use | INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) | 2026-05-19 | — | — | US | claimed |
| WO-2026086809-A1 | PROCESS FOR PREPARING 3- [ (3AS, 6AR) -5- {5-CHLORO-2- [ (1-METHYL-1H-PYRAZOL-4-YL) AMINO] PYRIMIDIN-4-YL} -3A-METHYL-OCTAHYDROPYRROLO [3, 4-C] PYRROLE-2-YL] -3-OXOPROPIONITRILE | BEIJING INNOCARE PHARMA TECH CO., LTD. (CN) | 2026-04-30 | — | — | WO | claimed |
| CN-120192277-A | Preparation method of etomidate | 仁合益康集团有限公司 | 2025-06-24 | — | — | CN | claimed |
| CN-116376043-B | Cadmium metal-organic framework material with long afterglow characteristic and preparation method thereof | 常州大学 | 2025-05-27 | — | — | CN | claimed |
| CN-119775545-A | Water-soluble polyester resin, plasma etching protection liquid containing same, and preparation method and application thereof | 深圳市化讯半导体材料有限公司 | 2025-04-08 | — | — | CN | claimed |
| CN-119771500-A | Cobalt-based crystalline catalyst with three-dimensional porous structure, and preparation method and application thereof | 上海应用技术大学 | 2025-04-08 | — | — | CN | claimed |
| US-20250100999-A1 | METHODS AND INTERMEDIATES FOR PREPARING THERAPEUTIC COMPOUNDS | GILEAD SCIENCES, INC. | 2025-03-27 | — | — | US | claimed |
| CN-116178746-B | Cadmium metal-organic framework material with long afterglow characteristic, preparation method and application | 常州大学 | 2025-03-18 | — | — | CN | claimed |
| CN-114660038-B | Preparation method and application of chiral core-shell type nano probe | 郑州大学 | 2024-12-03 | — | — | CN | claimed |
| CN-118947723-A | Fosthiazate microcapsule suspending agent, preparation method and application | 山东省绿士农药有限公司 | 2024-11-15 | — | — | CN | claimed |
| CN-111234505-A | Environment-friendly damping rubber plate and preparation method thereof | 谢强 | 2020-06-05 | — | — | CN | claimed |
| CN-111116655-A | Preparation method of high-optical-purity tenofovir benzyl ester phosphonamide prodrug | 天津天士力圣特制药有限公司 | 2020-05-08 | — | — | CN | claimed |
| CN-108997386-B | Zinc metal organic complex constructed by double ligands and preparation method thereof | 安徽理工大学 | 2020-05-08 | — | — | CN | claimed |
| WO-2018134836-A1 | A NOVEL, FEASIBLE AND COST EFFECTIVE PROCESS FOR THE MANUFACTURE OF D – PENICILLAMINE | SYNVEN SHREE LIFE SCIENCES PVT. LTD. (IN) | 2018-07-26 | — | — | WO | claimed |
| US-8541095-B2 | Security film and process for preparation thereof | SHANGHAI TECHSUN ANTI-COUNTERFEITING TECHNOLOGY HOLDING CO., LTD. (CN) | 2013-09-24 | — | — | US | claimed |
| EP-2329962-B1 | SECURITY FILM AND PROCESS FOR PREPARATION THEREOF | SHANGHAI TECHSUN ANTI COUNTERFEITING TECHNOLOGY HOLDING CO LTD (CN) | 2012-09-05 | — | — | EP | claimed |
| US-20110293858-A1 | SECURITY FILM AND PROCESS FOR PREPARATION THEREOF | SHANGHAI FUDAN TECHSUN NEW TECHNOLOGY CO. LTD. (CN) | 2011-12-01 | — | — | US | claimed |
| EP-2329962-A1 | SECURITY FILM AND PROCESS FOR PREPARATION THEREOF | Shanghai Fudan Techsun New Technology Co. Ltd. (CN) | 2011-06-08 | — | — | EP | claimed |
| CN-101323229-A | False proof thin film and preparation thereof | SHANGHAI FUDAN TECHSUN NEW TEC (CN) | 2008-12-17 | — | — | CN | claimed |
| US-4254053-A | Process for manufacturing D camphorate of L carnitinamide and D camphorate of D carnitinamide | Cavazza, Claudio (IT) | 1981-03-03 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250100999-A1 | METHODS AND INTERMEDIATES FOR PREPARING THERAPEUTIC COMPOUNDS | CYP11A1, CYP11B1, CYP11B2 | ALDH1A1 1161/4885LMNA 1143/4885POLB 361/4885 |
| US-12630520-B2 | Left-handed bicyclic morpholine and salt thereof, preparation method therefor, pharmaceutical composition, and use | GLS2, GOT1, MDH1 | ALDH1A1 336/4885LMNA 3724/4885POLB 2038/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.